<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="herein we summarize the origin, genetics, epidemiology, clinical manifestations, preventions," exact="diagnosis" post="and up to date treatments of SARS-CoV-2 infections in"/>
 <result pre="therapeutic approaches. SARS-CoV-2 epidemiology transmission temperature and humidity COVID-19 pneumonia" exact="diagnosis" post="ACE2 inhibitors therapeutics strategies 1. Introduction 1.1. What Are"/>
 <result pre="animal CoVs can also infect humans that can spread the" exact="infection" post="through human-to-human transmission [17,22]. On the other hand, Alpha-"/>
 <result pre="species as intermediate hosts before spreading to humans [59,60]. The" exact="detection" post="of two genomes distinct from known swine in ill"/>
 <result pre="January 13, 2020, Thailand announced the first non-Chinese case of" exact="infection" post="that spread from the Chinese provinces, to the Asian"/>
 <result pre="new type of coronavirus was isolated [60,91]. The epicenter of" exact="infection" post="was probably linked to a zoonotic pathogen being present"/>
 <result pre="range of temperatures and humidity may help to predict the" exact="prevalence" post="of this disease in terms of environmental characteristics. This"/>
 <result pre="severe and critical (Table 4) [57,76,105]. The symptoms of SARS-CoV-2" exact="infection" post="appear after an incubation period of 1 to 14"/>
 <result pre="Patients at this stage in intensive care unit (ICU) with" exact="quarantine" post="facilities may require mechanical ventilation. Moreover, bacterial infections can"/>
 <result pre="immediately reveal SARS-CoV-2 infected patients. This was particularly important for" exact="diagnosis" post="due to the difficulties in detecting specific clinical signs"/>
 <result pre="history of each patient played a fundamental role in COVID-19" exact="diagnosis" post="and up to now is considered one of the"/>
 <result pre="with clinical and laboratory tests are all required for the" exact="diagnosis" post="of COVID-19. A detailed description focused on clinical diagnostic"/>
 <result pre="Nucleic Acid Detection Technology High-throughput sequencing and real time quantitative" exact="polymerase chain reaction" post="(RT-qPCR) are the best nucleic acid detection techniques for"/>
 <result pre="quantitative polymerase chain reaction (RT-qPCR) are the best nucleic acid" exact="detection" post="techniques for SARS-CoV-2. However, in clinical diagnosis, the application"/>
 <result pre="RT-PCR method was chosen as the gold standard for the" exact="detection" post="of SARS-CoV-2 infections from the commonly used samples such"/>
 <result pre="[121]. The WHO has released numerous RT-PCR protocols for the" exact="detection" post="of SARS-CoV-2 RNA at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance (Accessed March 15, 2020)."/>
 <result pre="probes targeting the ORF1ab and N gene regions for SARS-CoV-2" exact="detection" post="by RT-PCR [123]. The positivity is confirmed when both"/>
 <result pre="that operator skills or sampling sources can profoundly affect RT-PCR" exact="testing" post="results [22]. Finally, during this pandemic several microbiologic labs"/>
 <result pre="as well as ready-to-use RT-PCR kits increasing the timing of" exact="diagnosis" post="confirmation through molecular approaches. Very recently, it was reported"/>
 <result pre="target genes bypassing the RNA extraction step for a faster" exact="diagnosis" post="[127]. 5.2. CT scans and Serology Methods Although RT-PCR"/>
 <result pre="scans and Serology Methods Although RT-PCR is specific for the" exact="diagnosis" post="of COVID-19, its false-negative rate cannot be overlooked due"/>
 <result pre="demonstrated the usefulness of CT and chest radiography for the" exact="diagnosis" post="of COVID-19 associated pneumonia [128]. Moreover, the ability of"/>
 <result pre="approach for the correct COVID-19 diagnosis. In particular, for early" exact="detection" post="and assessment of disease severity, the high-resolution CT (HRCT)"/>
 <result pre="sensibility of pulmonary imaging with respect to RT-PCR for COVID-19" exact="diagnosis" post="and showed a positive correlation between specific CT findings"/>
 <result pre="imaging revealed that AI could be used to support disease" exact="diagnosis" post="[133,134]. Ito et al. reviewed the literature on the"/>
 <result pre="study revealed the usefulness of AI approach to support the" exact="diagnosis" post="of COVID-19, but also for future emerging diseases [134]."/>
 <result pre="within 6 days after seroconversion. Importantly, the application of serology" exact="testing" post="in surveillance in a cluster of 164 close contacts"/>
 <result pre="studies underlined the recommended usage of serology to promote the" exact="detection" post="of SARS-CoV-2 infections where NP swab specimens were improperly"/>
 <result pre="Based on these data, several companies developed kits for IgM/IgG" exact="testing" post="showing a high detection rate of infected patients. Basically,"/>
 <result pre="several companies developed kits for IgM/IgG testing showing a high" exact="detection" post="rate of infected patients. Basically, there are two different"/>
 <result pre="detection rate of infected patients. Basically, there are two different" exact="testing" post="methods: the rapid IgG-IgM test and the classical enzyme-linked"/>
 <result pre="test. The rapid test consists in a lateral flow qualitative" exact="immunoassay" post="on a strip to detect the presence of both"/>
 <result pre="in 15 min leading to its useful application as point-of-care" exact="testing" post="and in supporting RT-PCR-based diagnostic [140]. On the other"/>
 <result pre="of IgA that seems high in the early stages of" exact="infection" post="(about 4 daysâ€™ post symptom development) [142,143]. Another interesting"/>
 <result pre="daysâ€™ post symptom development) [142,143]. Another interesting application of antibody" exact="detection" post="is represented by the fluorescence immuno-chromatographic assay for the"/>
 <result pre="detection is represented by the fluorescence immuno-chromatographic assay for the" exact="detection" post="of SARS-CoV-2 nucleocapsid protein in human specimens such as"/>
 <result pre="same type of sample that is commonly used for RT-PCR-based" exact="diagnosis" post="and high sensibility (detection of the nucleoprotein in all"/>
 <result pre="several governments, included Italy, are using serologic test for population" exact="screening" post="to assess the proportion of people that have developed"/>
 <result pre="that have developed an immunological response against SARS-CoV-2 (http://www.salute.gov.it/portale/nuovocoronavirus). This" exact="screening" post="will help also to detect asymptomatic and/or paucisymptomatic subjects."/>
 <result pre="infections in recent years, there is no official and effective" exact="treatment" post="against SARS-CoV-2. However, different considerable options have been applied"/>
 <result pre="Lianhuaqingwen and ShuFeng JieDu capsules may be helpful for SARS-CoV-2" exact="treatment" post="[12,150]. Indeed, this product is mainly used to treat"/>
 <result pre="shown to be a good target to significantly reduce pulmonary" exact="infection" post="in COVID-19 affected individuals (Figure 8I) [168] Moreover, it"/>
 <result pre="of the Peopleâ€™s Republic of China (NHC) guidelines for COVID-19" exact="treatment" post="(Figure 8I) (http://www.nhc.gov.cn). In particular, in vitro studies have"/>
 <result pre="a valid approach since it showed more rapid resolution of" exact="infection" post="than hydroxychloroquine alone [174]; however, the combined use of"/>
 <result pre="protease [176]. Moreover, a recent study by performing a virtual" exact="screening" post="using a three-dimensional model of the SARS-CoV-2 3C-like protease"/>
 <result pre="Induced Inflammatory Response In addition to antiviral therapy, a new" exact="treatment" post="strategy having a significant impact on clinical outcomes is"/>
 <result pre="downregulate the cytokine storm may provide great benefit to the" exact="treatment" post="of COVID-19. Recently, researchers focused on targeting specific molecular"/>
 <result pre="of infectious diseases. However, the use of corticosteroids in the" exact="treatment" post="of COVID-19 can cause host immune suppression and delay"/>
 <result pre="A recent study on 201 patients with ARDS showed that" exact="treatment" post="with methylprednisolone decreased the risk of death (hazard ratio"/>
 <result pre="recent retrospective study showed the potential benefits from low-dose corticosteroids" exact="treatment" post="in a subset of critically SARS-CoV-2 patients [182]; these"/>
 <result pre="there are no available data on the benefits of corticosteroid" exact="treatment" post="in SARS-CoV or MERS infection [183]. Apart from corticosteroids,"/>
 <result pre="on the benefits of corticosteroid treatment in SARS-CoV or MERS" exact="infection" post="[183]. Apart from corticosteroids, IL-6 pathway inhibitors such as"/>
 <result pre="antiviral agent may give physicians more time to provide supportive" exact="treatment" post="for patients with COVID-19. 6.5. Passive Immunization At the"/>
 <result pre="patients containing specific antibodies has been proposed as a principal" exact="treatment" post="[190,191], for patients in rapid disease progression, severe or"/>
 <result pre="that MSCs intravenous transplantation could represent a secure and effective" exact="treatment" post="in patients with COVID-19 pneumonia, especially those critical. Indeed,"/>
 <result pre="strategy seems to be a promising immunization approach against coronavirus" exact="infection" post="including SARS, MERS and other emerging infectious diseases. On"/>
 <result pre="years. If trials succeed, Oxford researchers have proposed to complete" exact="testing" post="throughout ring vaccination, namely delivering vaccine to members of"/>
 <result pre="must be vigilant and ready to advice appropriate containment and" exact="screening" post="measures to avoid the spread of any future emerging"/>
 <result pre="polypeptides (pps); porcine epidemic diarrhea virus (PEDV); real time quantitative" exact="polymerase chain reaction" post="(RT-qPCR); receptor-binding domain (RBD); recombinant human ACE2 (rhACE2); replicationâ€&quot;transcription"/>
 <result pre="J.2005241634164310.1038/sj.emboj.760064015791205 69.JiaH.P.LookD.C.ShiL.HickeyM.PeweL.NetlandJ.FarzanM.Wohlford-LenaneC.PerlmanS.McCrayP.B.Jr.ACE2 receptor expression and severe acute respiratory syndrome coronavirus" exact="infection" post="depend on differentiation of human airway epitheliaJ. Virol.200579146141462110.1128/JVI.79.23.14614-14621.200516282461 70.OrtegaJ.T.SerranoM.L.PujolF.H.RangelH.R.Role"/>
 <result pre="USA2020Available online: http://www.ncbi.nlm.nih.gov/pubmed/32150360(accessed on 4 July 2020) 77.HanY.YangH.The transmission and" exact="diagnosis" post="of 2019 novel coronavirus infection disease (COVID-19): A Chinese"/>
 <result pre="July 2020) 77.HanY.YangH.The transmission and diagnosis of 2019 novel coronavirus" exact="infection" post="disease (COVID-19): A Chinese perspectiveJ. Med. Virol.20201010.1002/jmv.25749 78.RothanH.A.ByrareddyS.N.The epidemiology"/>
 <result pre="83.ChenH.GuoJ.WangC.LuoF.YuX.ZhangW.LiJ.ZhaoD.XuD.GongQ.et al.Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: A retrospective review of medical"/>
 <result pre="GroupThe Allplex 2019-nCoV (Seegene) assay: Which performances are for SARS-CoV-2" exact="infection" post="diagnosis? [published online ahead of print, 28 May 2020]Eur."/>
 <result pre="al.Evaluating the accuracy of different respiratory specimens in the laboratory" exact="diagnosis" post="and monitoring the viral shedding of 2019-nCoV infectionsMedRxiv202010.1101/2020.02.11.20021493 126.BinnickerM.J.Emergence"/>
 <result pre="and Industry Is Essential to Control the OutbreakClin. Chem.20206666466610.1093/clinchem/hvaa07132077933 127.MerindolN.PÃ©pinG.MarchandC.RheaultM.PetersonC.PoirierA.HouleC.GermainH.DanyloA.SAS-CoV-2" exact="detection" post="by direct rRT-PCR without RNA extractionJ. Clin. Virol.202012810442310.1016/j.jcv.2020.10442332416598 128.ShiH.HanX.JiangN.CaoY.AlwalidO.GuJ.FanY.ZhengC.Radiological"/>
 <result pre="coronavirus disease 2019Diagn. Interv. Radiol.202010.5152/dir.2019.2029432436845 135.HuL.WangC.Radiological role in the detection," exact="diagnosis" post="and monitoring for the coronavirus disease 2019 (COVID-19)Eur. Rev."/>
 <result pre="al.CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)Radiology202029520220710.1148/radiol.202020023032017661 138.LuoL.LuoZ.JiaY.ZhouC.HeJ.LyuJ.ShenX.CT differential" exact="diagnosis" post="of COVID-19 and non-COVID-19 in symptomatic suspects: A practical"/>
 <result pre="application of a rapid IgM-IgG combined antibody test for SARS-CoV-2" exact="infection" post="diagnosisJ. Med. Virol.20201010.1002/jmv.25727 141.KohmerN.WesthausS.RÃ¼hlC.CiesekS.RabenauH.F.Brief clinical evaluation of six high-throughput"/>
 <result pre="medicine is expected to make greater contribution in controlling the" exact="prevalence" post="of influenzaBiosci. Trends2013725325610.5582/bst.2013.v7.5.25324241177 152.LinL.X.LiS.X.ZhengF.Y.Application of in Vitro Bionic Digestion"/>
 <result pre="spike proteinCell. Mol. Immunol.20201776576710.1038/s41423-020-0374-232047258 165.XiaS.LiuM.WangC.XuW.LanQ.FengS.QiF.BaoL.DuL.LiuS.et al.Inhibition of SARS-CoV-2 (previously 2019-nCoV)" exact="infection" post="by a highly potent pan-coronavirus fusion inhibitor targeting its"/>
 <result pre="novel clathrin- and caveolae-independent endocytic pathwayCell Res.20081829030110.1038/cr.2008.1518227861 171.RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.StebbingJ.Baricitinib as potential" exact="treatment" post="for 2019-nCoV acute respiratory diseaseLancet2020395e30e3110.1016/S0140-6736(20)30304-432032529 172.NeveuG.Ziv-AvA.Barouch-BentovR.BerkermanE.MulhollandJ.EinavS.AP-2-associated protein kinase 1"/>
 <result pre="of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: Virtual" exact="screening" post="reveals velpatasvir, ledipasvir, and other drug repurposing candidatesF1000Research2020912910.12688/f1000research.22457.232194944 178.MartinezM.A.Compounds"/>
 <result pre="coronavirus (2019-nCoV) in vitroCell Res.20203026927110.1038/s41422-020-0282-032020029 180.NguyenT.M.ZhangY.PandolfiP.P.Virus against virus: A potential" exact="treatment" post="for 2019-nCov (SARS-CoV-2) and other RNA virusesCell Res.20203018919010.1038/s41422-020-0290-032071427 181.ZhaL.LiS.PanL.TefsenB.LiY.FrenchN.ChenL.YangG.VillanuevaE.V.Corticosteroid"/>
 <result pre="treatment for 2019-nCov (SARS-CoV-2) and other RNA virusesCell Res.20203018919010.1038/s41422-020-0290-032071427 181.ZhaL.LiS.PanL.TefsenB.LiY.FrenchN.ChenL.YangG.VillanuevaE.V.Corticosteroid" exact="treatment" post="of patients with coronavirus disease 2019 (COVID-19)Med. J. Aust.202021241642010.5694/mja2.5057732266987"/>
 <result pre="pneumoniaSignal Transduct. Target Ther.202051310.1038/s41392-020-0127-932296011 183.RussellC.D.MillarJ.E.BaillieJ.K.Clinical evidence does not support corticosteroid" exact="treatment" post="for 2019-nCoV lung injuryLancet202039547347510.1016/S0140-6736(20)30317-232043983 184.KhanF.FabbriL.StewartI.RobinsonK.SmythA.R.JenkinsG.A systematic review of Anakinra,"/>
 <result pre="Speciality Collaboration, UKCOVID-19: Consider cytokine storm syndromes and immunosuppressionLancet20203951033103410.1016/S0140-6736(20)30628-032192578 187.LuoP.LiuY.QiuL.LiuX.LiuD.LiJ.Tocilizumab" exact="treatment" post="in COVID-19: A single center experienceJ. Med. Virol.20209281481810.1002/jmv.2580132253759 188.MichotJ.M.AlbigesL.ChaputN.SaadaV.PommeretF.GriscelliF.BalleyguierC.BesseB.MarabelleA.NetzerF.et"/>
 <result pre="COVID-19Eur. Respir. J.202055200085810.1183/13993003.00858-202032265310 196.ConnickP.KolappanM.CrawleyC.WebberD.J.PataniR.MichellA.W.DuM.Q.LuanS.L.AltmannD.R.ThompsonA.J.et al.Autologous mesenchymal stem cells for the" exact="treatment" post="of secondary progressive multiple sclerosis: An open-label phase 2a"/>
 <result pre="2a proof-of-concept studyLancet Neurol.20121115015610.1016/S1474-4422(11)70305-222236384 197.WilsonJ.G.LiuK.D.ZhuoH.CaballeroL.McMillanM.FangX.CosgroveK.VojnikR.CalfeeC.S.LeeJ.W.et al.Mesenchymal stem (stromal) cells for" exact="treatment" post="of ARDS: A phase 1 clinical trialLancet Respir. Med.20153243210.1016/S2213-2600(14)70291-725529339"/>
 <result pre="di SanitÃ , ISS). Figure 8 Schematic representation of SARS-CoV-2" exact="infection" post="and virus-induced human immune system response. Proposed drugs directed"/>
</results>
